STRYKER CORP

SYK NYSE CIK: 0000310764

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation MI
Business Address 1941 STRYKER WAY, PORTAGE, MI, 49002
Mailing Address 1941 STRYKER WAY, PORTAGE, MI, 49002
Phone 2693852600
Fiscal Year End 1231
EIN 381239739

Financial Overview

FY2025 FY

$25.12B
Revenue
$3.25B
Net Income
$47.84B
Total Assets
$25.42B
Total Liabilities
$4.01B
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report February 11, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 11, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC
4 Insider stock transaction report February 6, 2026 View on SEC

Annual Reports

10-K February 11, 2026
  • Stryker reported strong financial performance in 2024 with 10.2% revenue growth to $22.5 billion and 16.7% net income growth to $3.5 billion.
  • The company announced a pivotal $3.0 billion all-cash acquisition of Inari Medical Inc., significantly expanding its reach into high-growth interventional cardiology and peripheral vascular markets.
View Analysis

Insider Trading

STRONG SELL 3 insiders 20 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.